Clinical Trial Update: Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of combining 5-ALA with the CV01 ultrasound delivery system for sonodynamic therapy in patients with newly diagnosed high-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma

Drugs mentioned

• 5-ALA (5-aminolevulinic acid)
• CV01 ultrasound delivery platform (ultrasound delivery system for sonodynamic therapy)

Snippet

Sponsor: Universität Münster | Conditions: Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO) | Phase 1 | Status: COMPLETED